Less common are pathogenic variants in the ApoB gene, which encodes apolipoprotein B100 (ApoB100), and these variants may be the predominant cause of 5%–15% of FH cases, leading to reduced binding of LDL‐C to LDLR. The gene discussed is LDLR; the disease is familial hyperaldosteronism.